CKDXY - Opthea completes patient recruitment ahead of schedule in phase 2b wet AMD clinical trial November, 14 2018 06:19 AM Opthea Ltd ADR Opthea Limited (OTCPK:CKDXY) completes recruitment into ongoing Phase 2b trial of OPT-302 for wet age-related macular degeneration (AMD). More news on: Opthea Limited ADR, Healthcare stocks news, Read more ...